Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jan;62(1):36-42.
doi: 10.1136/thx.2006.059410. Epub 2006 Aug 23.

In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury

G D Perkins  1 , N Nathani, D F McAuley, F Gao, D R Thickett
Affiliations
Randomized Controlled Trial

In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury

G D Perkins et al. Thorax. 2007 Jan.

Abstract

Background: Intravenous salbutamol (albuterol) reduces lung water in patients with the acute respiratory distress syndrome (ARDS). Experimental data show that it also reduces pulmonary neutrophil accumulation or activation and inflammation in ARDS.

Aim: To investigate the effects of salbutamol on neutrophil function.

Methods: The in vitro effects of salbutamol on neutrophil function were determined. Blood and bronchoalveolar lavage (BAL) fluid were collected from 35 patients with acute lung injury (ALI)/ARDS, 14 patients at risk from ARDS and 7 ventilated controls at baseline and after 4 days' treatment with placebo or salbutamol (ALI/ARDS group). Alveolar-capillary permeability was measured in vivo by thermodilution (PiCCO). Neutrophil activation, adhesion molecule expression and inflammatory cytokines were measured.

Results: In vitro, physiological concentrations of salbutamol had no effect on neutrophil chemotaxis, viability or apoptosis. Patients with ALI/ARDS showed increased neutrophil activation and adhesion molecule expression compared with at risk-patients and ventilated controls. There were associations between alveolar-capillary permeability and BAL myeloperoxidase (r = 0.4, p = 0.038) and BAL interleukin 8 (r = 0.38, p = 0.033). In patients with ALI/ARDS, salbutamol increased numbers of circulating neutrophils but had no effect on alveolar neutrophils.

Conclusion: At the onset of ALI/ARDS, there is increased neutrophil recruitment and activation. Physiological concentrations of salbutamol did not alter neutrophil chemotaxis, viability or apoptosis in vitro. In vivo, salbutamol increased circulating neutrophils, but had no effect on alveolar neutrophils or on neutrophil activation. These data suggest that the beneficial effects of salbutamol in reducing lung water are unrelated to modulation of neutrophil-dependent inflammatory pathways.

PubMed Disclaimer

Conflict of interest statement

Competing interests: GDP, DFMcA and DRT have received payment to attend scientific meetings and have given talks for pharmaceutical companies that manufacture β‐ agonists (Astra Zeneca, GlaxoSmithKline).

References

    1. Rubenfeld G D, Caldwell E, Peabody E.et al Incidence and outcomes of acute lung injury. N Engl J Med 20053531685–1693. - PubMed
    1. Laufe M D, Simon R H, Flint A.et al Adult respiratory distress syndrome in neutropenic patients. Am J Med 1986801022–1026. - PubMed
    1. Abraham E. Neutrophils and acute lung injury. Crit Care Med 200331S195–S199. - PubMed
    1. Chollet‐Martin S. Polymorphonuclear neutrophil activation during the acute respiratory distress syndrome. Intens Care Med 2000261575–1577. - PubMed
    1. Steinberg K P, Milberg J A, Martin T R.et al Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994150113–122. - PubMed

Publication types

MeSH terms